Titan Pharmaceuticals
TTNP
#10546
Rank
โ‚น0.58 B
Marketcap
โ‚น437.54
Share price
-3.76%
Change (1 day)
30.39%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น416.65. In 2023 the company made an earnings per share (EPS) of -โ‚น703.28 an increase over its 2022 EPS that were of -โ‚น1,442.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น703.28-51.22%
2022-โ‚น1,442-15.61%
2021-โ‚น1,708-81.37%
2020-โ‚น9,168-77.52%
2019-โ‚น40,792-56.32%
2018-โ‚น93,392-59.51%
2017-โ‚น2,30,679-371.81%
2016โ‚น84,867-144.35%
2015-โ‚น1,91,340300%
2014-โ‚น47,835-121.54%
2013โ‚น2,22,091-151.38%
2012-โ‚น4,32,224-11.54%
2011-โ‚น4,88,601188.89%
2010-โ‚น1,69,131-10%
2009-โ‚น1,87,923
2007-โ‚น7,70,486-2.38%
2006-โ‚น7,89,279-39.13%
2005-โ‚น12,96,672-16.87%
2004-โ‚น15,59,765-22.43%
2003-โ‚น20,10,7814.9%
2002-โ‚น19,16,82061.9%
2001-โ‚น11,83,918-13.7%
2000-โ‚น13,71,84265.01%
1999-โ‚น8,31,382-35.87%
1998-โ‚น12,96,451-1824.71%
1997โ‚น75,169-102.4%
1996-โ‚น31,38,322

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,057-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น683.35-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น134.77-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น82.57-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.73-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น369.20-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA